Article Details

GenEros BioPharma's Clinflamozyde Approved for Clinical Trials for COVID-19 in the US

Retrieved on: 2021-05-21 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

GenEros BioPharma's Clinflamozyde Approved for Clinical Trials for COVID-19 in the US. View article details on HISWAI: https://www.einnews.com/pr_news/541689525/generos-biopharma-s-clinflamozyde-approved-for-clinical-trials-for-covid-19-in-the-us

Excerpt

GenEros BioPharma Ltd. is a clinical stage biotech company that strives to provide innovative therapeutics for unmet medical needs. Founded by Dr. Xin ...

Article found on: www.einnews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up